Literature DB >> 27565163

Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells.

Powrnima Joshi1, Mitra Kooshki2, Wayne Aldrich3, Daniel Varghai1, Maciej Zborowski1, Arun D Singh4, Pierre L Triozzi5,6.   

Abstract

Natural killer (NK) cells are implicated in the control of metastasis in uveal melanoma, a process that has been ascribed to its cancer stem cell subpopulation. NK cell activation is regulated by specific microRNA (miR). The NK cell sensitivity and regulatory miR production of uveal melanoma cancer stem cells was examined. Cancer stem cells enriched from aggressively metastatic MUM2B uveal melanoma cells by selecting CD271+ cells or propagating as non-adherent spheres in stem-cell supportive were more resistant to NK cell cytolysis than cancer stem cells enriched from less aggressively metastatic OCM1 uveal melanoma cells. Both MUM2B and OCM1 cells expressed and secreted NK cell regulatory miRs, including miR 146a, 181a, 20a, and 223. MUM2B cells expressed and secreted miR-155; OCM1 cells did not. Transfecting MUM2B cells with anti-miR-155 increased NK cell sensitivity. CD271+ cells were identified in the blood of patients with metastatic uveal melanoma and were characterized by low expression of melanocyte differentiation determinants and by the ability to form non-adherent spheres in stem-cell supportive media. These cells also expressed NK cell regulatory miRs, including miR-155. These results indicate that uveal melanoma cancer stem cells can vary in their sensitivity to NK cell lysis and their expression of NK cell regulatory miRs. Circulating CD271+ cells from patients with metastatic uveal melanoma manifest cancer stem cell features and express miRs associated with NK cell suppression, including miR-155, that may contribute to metastatic progression.

Entities:  

Keywords:  CD271; MHC class I-related chain A; Major histocompatibility complex class I molecules; Melanospheres; Microphthalmia-associated transcription factor; miR-155

Mesh:

Substances:

Year:  2016        PMID: 27565163      PMCID: PMC9082981          DOI: 10.1007/s10585-016-9815-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   4.510


  46 in total

1.  miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression.

Authors:  Xiaoxia Sun; Jian Zhang; Zhaohua Hou; Qiuju Han; Cai Zhang; Zhigang Tian
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells.

Authors:  A C Repp; E S Mayhew; S Apte; J Y Niederkorn
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.

Authors:  D J Blom; G P Luyten; C Mooy; S Kerkvliet; A H Zwinderman; M J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-08       Impact factor: 4.799

4.  Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma.

Authors:  Junfang Ji; Xin Zheng; Marshonna Forgues; Taro Yamashita; Eliane L Wauthier; Lola M Reid; Xinyu Wen; Young Song; Jun S Wei; Javed Khan; Snorri S Thorgeirsson; Xin Wei Wang
Journal:  Hepatology       Date:  2015-06-30       Impact factor: 17.425

5.  An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Meghan D Tuscan; J William Harbour
Journal:  J Mol Diagn       Date:  2010-04-22       Impact factor: 5.568

6.  Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.

Authors:  Gabriella Pietra; Claudia Manzini; Massimo Vitale; Mirna Balsamo; Emanuela Ognio; Monica Boitano; Paola Queirolo; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Int Immunol       Date:  2009-06-02       Impact factor: 4.823

Review 7.  Authenticating cell lines in ophthalmic research laboratories.

Authors:  Robert Folberg; Shrihari S Kadkol; Shahar Frenkel; Klara Valyi-Nagy; Martine J Jager; Jacob Pe'er; Andrew J Maniotis
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

8.  Translating uveal melanoma cytogenetics into clinical care.

Authors:  Bertil Damato; Sarah E Coupland
Journal:  Arch Ophthalmol       Date:  2009-04

9.  Repression of genes involved in melanocyte differentiation in uveal melanoma.

Authors:  Marjorie-Allison Bergeron; Sophie Champagne; Manon Gaudreault; Alexandre Deschambeault; Solange Landreville
Journal:  Mol Vis       Date:  2012-07-04       Impact factor: 2.367

10.  Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells.

Authors:  Han-Ching Tseng; Akihito Inagaki; Vickie T Bui; Nicholas Cacalano; Noriyuki Kasahara; Yan-Gao Man; Anahid Jewett
Journal:  J Cancer       Date:  2015-07-16       Impact factor: 4.207

View more
  8 in total

Review 1.  Emerging roles of microRNAs and their implications in uveal melanoma.

Authors:  Chun Yang; Yuejiao Wang; Pierre Hardy
Journal:  Cell Mol Life Sci       Date:  2020-08-11       Impact factor: 9.261

Review 2.  Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.

Authors:  Dhiraj Kumar; Mahadeo Gorain; Gautam Kundu; Gopal C Kundu
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

3.  The prognostic values of m6A RNA methylation regulators in uveal melanoma.

Authors:  Jing Tang; Qi Wan; Jianqun Lu
Journal:  BMC Cancer       Date:  2020-07-18       Impact factor: 4.430

Review 4.  Do Extracellular RNAs Provide Insight into Uveal Melanoma Biology?

Authors:  Cristina Barbagallo; Chiara Bianca Maria Platania; Filippo Drago; Davide Barbagallo; Cinzia Di Pietro; Michele Purrello; Claudio Bucolo; Marco Ragusa
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639

Review 5.  Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: therapeutic implications.

Authors:  Ioannis A Voutsadakis
Journal:  Cell Oncol (Dordr)       Date:  2018-02-22       Impact factor: 6.730

6.  Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.

Authors:  Jian Ma; Di Yang; Xiao-Xin Ma
Journal:  Aging (Albany NY)       Date:  2021-06-16       Impact factor: 5.682

7.  Extracellular Protease ADAMTS1 Is Required at Early Stages of Human Uveal Melanoma Development by Inducing Stemness and Endothelial-Like Features on Tumor Cells.

Authors:  Carlos Peris-Torres; María Del Carmen Plaza-Calonge; Raúl López-Domínguez; Silvia Domínguez-García; Antonio Barrientos-Durán; Pedro Carmona-Sáez; Juan Carlos Rodríguez-Manzaneque
Journal:  Cancers (Basel)       Date:  2020-03-27       Impact factor: 6.639

Review 8.  Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives.

Authors:  Arnaud Martel; Stephanie Baillif; Sacha Nahon-Esteve; Lauris Gastaud; Corine Bertolotto; Barnabé Roméo; Baharia Mograbi; Sandra Lassalle; Paul Hofman
Journal:  Cancers (Basel)       Date:  2020-11-06       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.